Simponi Aria Leads to Sustained Improvements in Quality of Life for Adults with Active AS, Phase 3 Trial Shows
Treatment with Simponi Aria (golimumab) led to clinically meaningful improvements in health-related quality of life in adults with ankylosing spondylitis after four months — benefits that were maintained over one year, a Phase 3 trial shows. The findings were presented in a poster, titled “Effects of…